Patents by Inventor Annika Bjore

Annika Bjore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oxabispidine compounds for the treatment of cardiac arrhythmias
    Patent number: 7928225
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R41 to R46, X, Y and Z have meanings given in the description, which compounds are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Grant
    Filed: June 12, 2006
    Date of Patent: April 19, 2011
    Assignee: AstraZeneca AB
    Inventors: Annika Björe, David Cladingboel, Gareth Ensor, Adam Herring, Johan Kajanus, Robert Lundqvist, Christina Olsson, Carl-Gustav Sigfridsson, Gert Strandlund
  • Isoindoline Derivatives For The Treatment Of Arrhythmias
    Publication number: 20100298392
    Abstract: There is provided compounds of formula I, wherein R1 to R7 have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: July 12, 2007
    Publication date: November 25, 2010
    Applicant: ASTRAZENECA AB
    Inventors: Annika Bjore, Jonas Bostrom, Ojvind Davidsson, Hans Emtenas, Ulrik Gran, Tommy Iliefski, Johan Kajanus, Roine Olsson, Lars Sandberg, Gert Strandlund, Johan Sundell, Zhong-Qing Yuan
  • Oxabispidine compounds useful in the treatment of cardiac arrhythmias
    Patent number: 7772229
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Grant
    Filed: March 22, 2006
    Date of Patent: August 10, 2010
    Assignee: AstraZeneca AB
    Inventors: Annika Björe, Magnus Björsne, Kurt-Jürgen Hoffmann, Fritiof Pontėn, Gert Strandlund, Peder Svensson, Michael Wilsterman
  • Oxabispidine compounds and their use in the treatment of cardiac arrhythmias
    Patent number: 7648985
    Abstract: There is provided compounds of formula (I), wherein R1, R2, R3, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Grant
    Filed: June 13, 2005
    Date of Patent: January 19, 2010
    Assignee: AstraZeneca AB
    Inventors: Annika Bjore, Ulrik Gran, Peter Bonn, Johan Kajanus, Christina Olsson, Fritiof Ponten
  • New oxabispidine compunds useful in the treatment of cardiac arrhythmias
    Publication number: 20090326221
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: September 1, 2009
    Publication date: December 31, 2009
    Applicant: AstraZeneca AB,
    Inventors: Annika Bjore, Magnus Bjorsne, David Cladingboel, Kurt-Jurgen Hoffman, John Pavey, Fritiof Ponten, Gert Strandlund, Peder Svensson, Colin Thomson, Michael Wilsterman
  • Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias
    Publication number: 20090270383
    Abstract: There is provided compounds of formula (I), wherein R1, R2, R3, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: July 6, 2009
    Publication date: October 29, 2009
    Applicant: AstraZeneca AB
    Inventors: Annika Bjore, Peter Bonn, Ulrik Gran, Johan Kajanus, Christina Olsson, Fritiof Ponten
  • Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias
    Publication number: 20090099162
    Abstract: There is provided compounds of formula I, wherein R1, R2, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: February 11, 2008
    Publication date: April 16, 2009
    Applicant: AstraZeneca AB
    Inventors: Annika Bjore, Ulrik Gran, Gert Strandlund
  • New Oxabispidine Compounds For The Treatment Of Cardiac Arrhythmias
    Publication number: 20090054422
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R41 to R46, X, Y and Z have meanings given in the description, which compounds are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: June 12, 2006
    Publication date: February 26, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Annika Bjore, David Cladingboel, Gareth Ensor, Adam Herring, Johan Kajanus, Robert Lundqvist, Christina Olsson, Carl-Gustav Sigfridsson, Gert Strandlund
  • Novel Oxabispidine Compounds and Their Use in the Treatment of Cardiac Arrhythmias
    Publication number: 20090005558
    Abstract: There is provided compounds of formula (I), wherein R1, R2, R3, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: June 13, 2005
    Publication date: January 1, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Annika Bjore, Peter Bonn, Ulrik Gran, Johan Kajanus, Christina Olsson, Fritiof Ponten
  • Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias
    Publication number: 20080319198
    Abstract: There is provided compounds of formula I, wherein R1, R2, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: February 12, 2008
    Publication date: December 25, 2008
    Applicant: AstraZeneca AB
    Inventors: Annika Bjore, Ulrik Gran, Gert Strandlund
  • Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias
    Publication number: 20080249086
    Abstract: There is provided compounds of formula I, wherein R1, R2, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: February 11, 2008
    Publication date: October 9, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Annika Bjore, Ulrik Gran, Gert Strandlund
  • Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias
    Publication number: 20080207899
    Abstract: There is provided compounds of formula I, wherein R1, R2, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: February 12, 2008
    Publication date: August 28, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Annika Bjore, Ulrik Gran, Gert Strandlund
  • Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias
    Publication number: 20080146812
    Abstract: There is provided compounds of formula I, wherein R1, R2, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: February 12, 2008
    Publication date: June 19, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Annika Bjore, Ulrik Gran, Gert Strandlund
  • Oxabispidine compounds and their use in the treatment of cardiac arrhythmias
    Patent number: 7354917
    Abstract: There is provided compounds of formula I, wherein R1, R2, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular a trial and ventricular arrhythmias.
    Type: Grant
    Filed: June 13, 2005
    Date of Patent: April 8, 2008
    Assignee: AstraZeneca AB
    Inventors: Annika Bjore, Ulrik Gran, Gert Strandlund
  • Oxabispidine compounds useful in the treatment of cardiac arrhythmias
    Patent number: 7351821
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Grant
    Filed: December 18, 2006
    Date of Patent: April 1, 2008
    Assignee: AstraZeneca AB
    Inventors: Annika Björe, Magnus Björsne, David Cladingboel, Kurt-Jürgen Hoffmann, John Pavey, Fritiof Pontén, Gert Strandlund, Peder Svensson, Colin Thomson, Michael Wilsterman
  • NEW COMPOUNDS I/418
    Publication number: 20080015237
    Abstract: There is provided compounds of formula I, wherein R1 to R7 have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: July 11, 2007
    Publication date: January 17, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Annika Bjore, Jonas Bostrom, Ojvind Davidsson, Hans Emtenas, Ulrik Gran, Tommy Iliefski, Johan Kajanus, Roine Olsson, Gert Strandlund, Johan Sundell, Zhong-Qing Yuan, Lars Sandberg
  • Novel Oxabispidine Compounds and Their Use in the Treatment of Cardiac Arrhythmias
    Publication number: 20070259864
    Abstract: There is provided compounds of formula I, wherein R1, R2, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: June 13, 2005
    Publication date: November 8, 2007
    Applicant: ASTRAZENECA AB
    Inventors: Annika Bjore, Ulrik Gran, Gert Strandlund
  • Oxabispidine compounds useful in the treatment of cardiac arrhythmias
    Publication number: 20070117799
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: December 18, 2006
    Publication date: May 24, 2007
    Inventors: Annika Bjore, Magnus Bjorsne, David Cladingboel, Kurt-Jurgen Hoffmann, John Pavey, Fritiof Ponten, Gert Strandlund, Peder Svensson, Colin Thomson, Michael Wilsterman
  • 3,7-Diazabicyclo [3.3.1] formulations as anti-arrhythmic compounds
    Patent number: 7217708
    Abstract: There is provided substantially crystalline forms of 4-({3-[7-(3,3-dimethyl-2-oxobutyl) -9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl]propyl}amino)benzo-nitrile; tert-butyl 2 -{7-[3-(4-cyanoanilino)propyl]-9-oxa-3,7-diazabicyclo-[3.3.1]non-3-yl}ethylcarbamate; tert-butyl 2-{7-[4-(4-cyanophenyl)butyl]-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl}ethylcarbamate; or tert-butyl 2-{7-[2S)-3-(4-cyanophenoxy)-2-hydroxypropyl]-9-oxa-3,7-diazabicyclo-[3.3.1]non-3-yl}ethylcarbamate and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of cardiac arhythmias.
    Type: Grant
    Filed: April 12, 2002
    Date of Patent: May 15, 2007
    Assignee: Astrazeneca AB
    Inventors: Neil Barnwell, Annika Björe, Lal Cheema, David Cladingboel, Adam Herring, Karin Lövqvist
  • New oxabispidine compounds useful in the treatment of cardiac arrhythmias
    Publication number: 20060166979
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Application
    Filed: March 22, 2006
    Publication date: July 27, 2006
    Applicant: AstraZeneca AB
    Inventors: Annika Bjore, Magnus Bjorsne, Kurt-Jurgen Hoffmann, Fritiof Ponten, Gert Strandlund, Peder Svensson, Michael Wilsterman